We are live on
!
Find out more
Supernus Pharmaceuticals
SUPN
SUPN
53 hedge funds and large institutions have $170M invested in Supernus Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
572% more call options, than puts
Call options by funds: $5.84M | Put options by funds: $869K
Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.1%
New
53
Increased
–
Reduced
–
Closed
–
Calls
$5.84M
Puts
$869K
Net Calls
+$4.97M
Net Calls Change
+$4.97M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| $4K | +$3.7K | +628 | New |
|
52
California Public Employees Retirement System
Sacramento,
California
| $1K | +$589 | +100 | New |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$59 | +10 | New |
|
SUPN Hedge Fund Activity: Q2 2013 in Review
53 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q2 2013, worth a combined $170M.
Buyers outnumbered sellers: 53 funds opened new SUPN positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.
- 53 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $170M of Supernus Pharmaceuticals stock for Q2 2013.
- 53 funds opened new Supernus Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +53 holders.
Based on aggregated 13F filings for Q2 2013.